6 Methoxy 2 R 4 Methoxy 3 5 Dimethylpyridin 2 Yl Methyl Sulfinyl 1h Benzimidazole
quinoline thiophene imidazole thiazole

6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole

    Specifications

    HS Code

    942733

    Chemical Name 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
    Molecular Formula C20H23N3O3S
    Molecular Weight 385.48 g/mol
    Appearance Typically appears as a solid (description may vary based on purity and form)
    Melting Point Specific melting point data would require experimental determination
    Boiling Point Boiling point data would need experimental determination
    Solubility Solubility characteristics would depend on the solvent; likely has limited solubility in water
    Pka pKa values would be determined by the acidic or basic functional groups in the molecule
    Logp LogP value (lipophilicity parameter) would need to be calculated or experimentally determined
    Chirality Contains a chiral center, indicated by the (R) configuration

    As an accredited 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Storage
    Shipping
    Free Quote

    Competitive 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to info@alchemist-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: info@alchemist-chem.com

    General Information
    Where to Buy 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole in China?
    As a trusted 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole manufacturer, we deliver: Factory-Direct Value: Competitive pricing with no middleman markups, tailored for bulk orders and project-scale requirements.Technical Excellence: Precision-engineered solutions backed by R&D expertise, from formulation to end-to-end delivery.Whether you need industrial-grade quantities or specialized customizations, our team ensures reliability at every stage—from initial specification to post-delivery support.
    Frequently Asked Questions

    As a leading 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.

    What is the chemical structure of 6-methoxy-2- { (R) - [ (4-methoxy-3, 5-dimethylpyridin-2-yl) methyl] sulfinyl} -1H-benzimidazole
    This is the chemical name of pantoprazole. Its chemical structure is exquisitely constructed from many parts. Looking at its name, it contains the main nucleus of benzimidazole, which is a type of structure with unique chemical activity and is common in many drug molecules. 6-methoxy group, which is a methoxy group added to the 6 position of the benzimidazole ring. Methoxy group is the power supply group, which can affect the electron cloud distribution and chemical properties of molecules.
    Furthermore, the 2 - { (R) - [ (4-methoxy-3,5-dimethylpyridine-2-yl) methyl] sulfinyl} part, the pyridine ring is also a common nitrogen-containing heterocyclic ring, and the substitution of 4-methoxy with 3,5-dimethyl gives the pyridine ring a specific electronic effect and steric resistance. The (R) -configuration indicates that this structure is chiral. The sulfinyl group connects the pyridine ring to the benzimidazole ring, which is like a bridge, connecting two important structural units. The interaction of various parts makes pantoprazole have unique chemical properties and pharmacological activities, and is often used as a proton pump inhibitor for the treatment of gastric acid-related diseases.
    What is the main use of 6-methoxy-2- { (R) - [ (4-methoxy-3, 5-dimethylpyridin-2-yl) methyl] sulfinyl} -1H-benzimidazole
    6-Methoxy-2 - { (R) - [ (4-methoxy-3,5-dimethylpyridine-2-yl) methyl] sulfinyl} -1H-benzimidazole, which is the chemical name of pantoprazole. Pantoprazole is a benzimidazole proton pump inhibitor, which is widely used in the medical tract.
    Its primary use is for the treatment of gastric ulcers. In the stomach, due to excessive gastric acid secretion or Helicobacter pylori invasion, the gastric mucosa is easily damaged, resulting in ulcers. Pantoprazole can inhibit the activity of proton pump in gastric wall cells, reduce gastric acid secretion, create a good environment for ulcer healing, relieve epigastric pain, acid reflux, belching and other symptoms.
    Furthermore, this drug is also commonly used in the disease of duodenal ulcer. The duodenum is prone to ulcers due to gastric acid irritation. Pantoprazole can effectively reduce the concentration of gastric acid, reduce the irritation of the duodenal mucosa, promote the repair and healing of the ulcer surface, and relieve the suffering of patients.
    Reflux esophagitis is also a suitable disease. When the lower esophageal sphincter is dysfunctional, gastric acid reflows to the esophagus, burning the esophageal mucosa and causing inflammation. Pantoprazole helps the esophageal mucosa return to normal by inhibiting gastric acid secretion, reducing the damage of reflux gastric acid to the esophageal mucosa, relieving heartburn, chest pain and other discomforts.
    In addition, pantoprazole is often used in combination with antibiotics to eradicate Helicobacter pylori. Helicobacter pylori is closely related to many gastric diseases. Pantoprazole reduces gastric acid, creates a suitable environment for antibiotics to play a role, improves the eradication rate of Helicobacter pylori, and prevents the recurrence of related diseases.
    What is the pharmacological mechanism of 6-methoxy-2- { (R) - [ (4-methoxy-3, 5-dimethylpyridin-2-yl) methyl] sulfinyl} -1H-benzimidazole
    6-Methoxy-2- { (R) - [ (4-methoxy-3,5-dimethylpyridine-2-yl) methyl] sulfinyl} -1H-benzimidazole, its pharmacological mechanism is also related to various things in the stomach. This drug can prevent the secretion of gastric acid, and it can be closely linked to the proton pump of gastric wall cells. This pump is called H
    When gastric wall cells want to secrete acid, the proton pump plays a key role, which can transport hydrogen protons out of the cell for potassium ions. This drug can form a covalent bond with the thiol group of cysteine residues in the proton pump, causing the loss of proton pump activity, then the secretion of gastric acid is blocked, and the amount of gastric acid is reduced.
    Its mechanism is unique, unlike other acid-making agents. For example, anticholinergics block the combination of acetylcholine and parietal cell receptors to reduce gastric acid; H2O receptor antagonists inhibit the response of histamine and H2O receptors, making gastric acid less secreted. This drug directly attacks the proton pump and blocks the root source of gastric acid secretion, so it has a strong and long-lasting effect. It can raise the pH value in the stomach and maintain the acid-base balance in the stomach for a long time. In this way, various diseases related to gastric acid, such as gastric ulcer, duodenal ulcer, reflux esophagitis, etc., are effective, and can protect the mucosa of the stomach and esophagus and promote their recovery.
    What are the adverse reactions of 6-methoxy-2- { (R) - [ (4-methoxy-3, 5-dimethylpyridin-2-yl) methyl] sulfinyl} -1H-benzimidazole
    6-Methoxy-2 - { (R) - [ (4-methoxy-3,5-dimethylpyridine-2-yl) methyl] sulfinyl} -1H-benzimidazole, which is the chemical name of the drug lansoprazole. Although it is a good medicine for treating gastric acid-related diseases, it also has some adverse reactions.
    Looking at its adverse reactions, one is the blood system, or it can cause leukopenia and thrombocytopenia, which is related to the foundation of human immunity and coagulation. If soldiers are reduced, it will affect the body's defense and repair. The two involve the digestive system, and common nausea, vomiting, diarrhea, constipation, etc. If the stomach and intestines are like a city, the transportation and transportation are disturbed, such as disorder in the order of the city. The three can cause headache, dizziness, drowsiness or insomnia in the mental nervous system. The human spirit is like a lamp, and this medicine may cause its light and dark to be impermanent. The four may affect the function of the liver, causing an increase in transaminase. If the liver is like a workshop, the enzyme change indicates that its labor is abnormal. The five may have skin rash, itching, skin like clothing, and itching makes clothing uncomfortable.
    Although this medicine has all kinds of adverse reactions, under the consideration of doctors, it can be used symptomatically and can often cure diseases. When taking medicine, doctors must carefully observe the situation and deal with it cautiously.
    6-Methoxy-2- { (R) - [ (4-methoxy-3, 5-dimethylpyridin-2-yl) methyl] sulfinyl} -1H-benzimidazole
    6-Methoxy-2 - { (R) - [ (4-methoxy-3,5-dimethylpyridine-2-yl) methyl] sulfinyl} -1H-benzimidazole, which is an important compound in the field of medicine, its market prospect is quite promising.
    In this world, there are many patients with gastrointestinal diseases, and such compounds are often the key ingredients of related drugs, which can effectively relieve gastrointestinal discomfort. Its effect on gastric acid secretion inhibition and other aspects is significant, so the market demand for the treatment of digestive system diseases is quite large.
    As far as the research and development situation is concerned, many pharmaceutical companies and scientific research institutions have favored it, investing a lot of resources to explore its new uses and new dosage forms. The development of new dosage forms is expected to improve the efficacy of drugs and optimize the patient's medication experience.
    From the perspective of market competition, some products have been successfully launched and occupy a certain share in the market. However, with the advancement of research and development, there are not a few new entrants, and the competition is becoming increasingly fierce. If companies want to come out on top in the market, they must make more efforts in quality control, cost control and innovative research and development.
    Furthermore, with the improvement of public health awareness, the demand for gastrointestinal disease treatment drugs is not only for their effectiveness, but also for their safety and convenience. If this compound can make a breakthrough at this end and meet market demand, it will surely achieve great results in the future market, with a promising future.